Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Jenoptik Grows its Components Portfolio Through Acquisitions

Facebook Twitter LinkedIn Email
Jenoptik will acquire Berliner Glas Medical Applications GmbH (Berliner Glas Medical), SwissOptic AG, and SwissOptic (Wuhan) Co. Ltd. Jenoptik is acquiring the companies from Berliner Glas GmbH, a wholly owned subsidiary of ASML Holding NV.

Berliner Glas was acquired by lithography systems manufacturer ASML in 2020. “Jenoptik will deepen its existing, long-standing business relationship with ASML, one of the key players in the semiconductor industry, as a reliable supplier and strategic partner,” Jenoptik said in a press release.

BG Medical Applications, based in Berlin, is a supplier of high-precision, custom optical components for the medical technology sector. Jenoptik will acquire its product portfolio in the fields of dentistry (intraoral scanners) and robotic surgery.

SwissOptic, headquartered in Heerbrugg, Switzerland, is a developer and manufacturer of optical components and assemblies, primarily for the medical technology, semiconductor, and metrology industries. The acquisition strengthens Jenoptik’s ophthalmology and life sciences business, and allows Jenoptik to approximately double the size of its medical technology business.

Jenoptik said the purchase price for the combined acquisition is around €300 million ($349.7 million). In 2022, the acquired companies are expected to contribute approximately €130 million ($151.5 million) in revenue.

Jan/Feb 2022
acquisitionsBusinesslithographyopticsmaterialsBiophotonicsTest & MeasurementIndustry NewsBioScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.